Emory University is uniquely positioned to train a cadre of scientists with expertise in multi-disciplinary approaches to vaccines. The faculty preceptors for the Emory Interdisciplinary Vaccinology Training Program (IVTP) have the breadth of expertise and mentoring experience that is critical for training a new generation of Vaccinologists. They are affiliated with several colleges and research facilities at Emory, including the Emory School of Medicine, the Rollins School of Public Health, the Emory Vaccine Center and the joint Emory-Georgia Institute of Technology (GA Tech) Biomedical Engineering Department at Emory. Faculty have extensive training experience and also represent several disciplines, including microbiology and immunology, rheumatology, infectious diseases, obstetrics/gynecology, pathology, pediatrics, epidemiology, global health, and health policy. The proposed IVTP will bridge these areas by bringing together trainees with diverse backgrounds to create an environment in which they will be exposed to and learn to interact with specialists engaged in all aspects of vaccine research. The IVTP will support four postdoctoral fellows (MD, PhD, or MD/PhD) to engage in full-time research training. Through formal and informal education, mentored research, and career mentoring, the IVTP trainees will acquire the skills and background necessary for their success as Vaccinology leaders in the future. Each IVTP trainee will select an in-depth research project from one of four Research Training Sections: 1) Pathogenesis &Vaccine Discovery;2) Innate &Adaptive Immune Responses to Bacterial, Protozoal, &Viral Antigens;3) Vaccine Epidemiology &Health Policy;and 4) Translation, Delivery &Clinical Trials. Each trainee will participate in the Masters of Science in Clinical Research (MSCR) program, as well as two comprehensive graduate level courses emphasizing different aspects of the field of Vaccinology. The specific goals of the IVTP include: To inspire and attract outstanding post-doctoral trainees to pursue interdisciplinary training in preparation for independent vaccinology research careers; To integrate the strong basic science, translational research, and clinical trials programs at Emory into a multi-faceted training experience, producing a synergistic whole greater than the sum of its individual parts; To train MD and PhD scientists committed to careers in vaccine research to incorporate novel basic science tools into Vaccinology and public health; To provide each trainee with formal and informal vaccinology education, a mentoring team for his or her collaborative multidisciplinary research project, and vaccinology career mentoring.

Public Health Relevance

This application responds to an urgent need to train a new generation of Vaccinologists. Vaccines have dramatically reduced the spread of infectious diseases, show great potential for preventing and controlling chronic conditions, and are highly cost-effective. However, to achieve the full potential of vaccines and address difficulties that have hindered progress, a new generation of well-prepared scientists is needed.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Institutional National Research Service Award (T32)
Project #
5T32AI074492-04
Application #
8269005
Study Section
Microbiology and Infectious Diseases B Subcommittee (MID)
Program Officer
Mcsweegan, Edward
Project Start
2009-08-01
Project End
2014-05-31
Budget Start
2012-06-01
Budget End
2013-05-31
Support Year
4
Fiscal Year
2012
Total Cost
$272,667
Indirect Cost
$23,155
Name
Emory University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Myers, Tanya R; McNeil, Michael M; Ng, Carmen S et al. (2017) Adverse events following quadrivalent meningococcal CRM-conjugate vaccine (Menveo®) reported to the Vaccine Adverse Event Reporting system (VAERS), 2010-2015. Vaccine 35:1758-1763
Rouphael, Nadine G; Paine, Michele; Mosley, Regina et al. (2017) The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial. Lancet 390:649-658
Aceituno, Anna M; Stanhope, Kaitlyn K; Rebolledo, Paulina A et al. (2017) Using a monitoring and evaluation framework to improve study efficiency and quality during a prospective cohort study in infants receiving rotavirus vaccination in El Alto, Bolivia: the Infant Nutrition, Inflammation, and Diarrheal Illness (NIDI) study. BMC Public Health 17:911
Boyoglu-Barnum, S; Todd, S O; Meng, J et al. (2017) Mutating the CX3C Motif in the G Protein Should Make a Live Respiratory Syncytial Virus Vaccine Safer and More Effective. J Virol 91:
Phadke, Varun K; Jacob, Jesse T (2016) Marvelous but Morbid: Infective endocarditis due to Serratia marcescens. Infect Dis Clin Pract (Baltim Md) 24:143-150
Kabbani, Sarah; Jacob, Jesse T; Gaynes, Robert P et al. (2016) Decrease in Candida bloodstream infections in veterans in Atlanta. Am J Infect Control 44:488-90
Phadke, Varun K; Bednarczyk, Robert A; Salmon, Daniel A et al. (2016) Association Between Vaccine Refusal and Vaccine-Preventable Diseases in the United States: A Review of Measles and Pertussis. JAMA 315:1149-58
Omer, Saad B; Phadke, Varun K; Bednarczyk, Robert A et al. (2016) Impact of Statins on Influenza Vaccine Effectiveness Against Medically Attended Acute Respiratory Illness. J Infect Dis 213:1216-23
McCarthy, Natalie L; Gee, Julianne; Sukumaran, Lakshmi et al. (2016) Vaccination and 30-Day Mortality Risk in Children, Adolescents, and Young Adults. Pediatrics 137:e20152970
Burke, Rachel M; Suchdev, Parminder S; Rebolledo, Paulina A et al. (2016) Predictors of Inflammation in a Cohort of Bolivian Infants and Toddlers. Am J Trop Med Hyg 95:954-963

Showing the most recent 10 out of 76 publications